Longtime Pfizer R&D chief Kathy Fernando, Ph.D., has left the Big Pharma behind to take on the role of chief business officer at San Diego biotech Replicate Bioscience. There, she’ll work to advance ...

Qlik, a data integration, data quality, analytics, and artificial intelligence (AI) solutions provider, today previewed its new agentic experience in Qlik Cloud delivered through Qlik Answers as the ...

Cloudflare Inc. has acquired Replicate Inc., a startup with software that makes it easier to deploy artificial intelligence models in production. The companies announced the transaction today without ...

Cloudflare (NET) announced it has reached an agreement to acquire Replicate, which will give developers on its Workers platform access to tens of thousands of artificial intelligence models. Replicate ...

Science is a process of continuous discovery, built on the foundation of prior research. A core principle of the scientific method is that experiments should be reproducible, meaning other scientists ...

Qlik announced the rapid adoption of Qlik Predict, a no-code predictive analytics platform designed for business users. The solution, announced Oct. 1, aims to transform how organizations leverage ...

Ritwik is a passionate gamer who has a soft spot for JRPGs. He's been writing about all things gaming for six years and counting. No matter how great a title's gameplay may be, there's always the ...

I am currently reading Pascal Bornet’s Irreplaceable: The Art of Standing Out in the Age of Artificial Intelligence. In this book, Bornet introduces a concept he calls Humics: a set of uniquely human ...

Aug 28 (Reuters) - Replicate Bioscience will partner with Novo Nordisk (NOVOb.CO), opens new tab to develop treatments using self-replicating RNA technology for obesity, type 2 diabetes and other ...

As obesity pioneer Novo Nordisk loses ground in the race for next-generation drugs, the Danish pharma giant is betting on novel RNA technology to bolster its early-stage pipeline. Novo has inked a ...

Novo vaulted into the ranks of the world’s most valuable drugmakers in recent years after introducing Ozempic for diabetes and Wegovy for obesity. Rival Eli Lilly had similar success with its entrants ...

Most people regard bank runs as a thing of the Depression-era past, but in 2023, several U.S. financial institutions failed when they experienced unexpected runs on deposits. Taking notice, leaders at ...